APP and Alzheimer disease: A higher frequency study (1950 MHz) showed decreased AD pathology in Tg-5xFAD transgenic mice, which overexpress APP, and wild type (WT) mice treated with REMFS at 1950 MHz with SAR 5 W/kg for 2 h per day, 5 days per week [56].